[Bronchopulmonary complications of antirheumatic drugs].
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D001982:Bronchial Diseases / Q000139:chemically induced*; D001986:Bronchial Spasm / Q000139:chemically induced; D004338:Drug Combinations / Q000009:adverse effects; D005260:Female; D005944:Glucosamine / Q000009:adverse effects / Q000031:analogs & derivatives; D006046:Gold / Q000009:adverse effects; D006801:Humans; D008171:Lung Diseases / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D010396:Penicillamine / Q000009:adverse effects; D011658:Pulmonary Fibrosis / Q000139:chemically induced; D012216:Rheumatic Diseases / Q000188:drug therapy; D012460:Sulfasalazine / Q000009:adverse effects
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D004338:Drug Combinations; C028423:Salazopyrine; D012460:Sulfasalazine; D006046:Gold; D010396:Penicillamine; D005944:Glucosamine
Les complications broncho-pulmonaires des médications antirhumatismales.